pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Peptide Therapeutic · news · pharmadog
← back to Peptide Therapeutic
News · Peptide Therapeutic
94
stories
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
2d
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
3d
Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
fiercebiotech
3d
Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate
fiercebiotech
6d
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
7d
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
biospace
8d
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision
fiercebiotech
8d
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
biopharma dive
9d
After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
fiercebiotech
11d
Silence brings the noise to Takeda with phase 2 blood cancer win
fiercebiotech
15d
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
16d
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
biospace
16d
Amgen drops early-stage obesity drug, upping pressure on MariTide
fiercebiotech
16d
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
fiercebiotech
16d
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout
fiercebiotech
21d
Key Senate panel backs Trump’s picks for CDC, pandemic preparedness
stat
21d
STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels
stat
21d
STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
stat
21d
Ebola outbreak nears milestone, while a vaccine remains months away
stat
21d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
22d
FDA updates product-specific guidelines for injectable peptides
raps
22d
FDA unveils FY 2027 user fee rates
raps
22d
STAT+: End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs
stat
22d
STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
stat
22d
Fauci invokes Fifth Amendment in declining to answer questions before Senate panel
stat
22d
A neglected issue in pedestrian, biker deaths
stat
23d
Six key issues we’re watching at Fauci’s hearing
stat
23d
Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
stat
23d
The future of gray-market peptides
endpoints
23d
STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
stat
← prev
page 1 of 4
next →
